Published in Int J Pediatr on October 23, 2013
Design, implementation, and evaluation of a pediatric and adolescent type 2 diabetes management program at a tertiary pediatric center. J Multidiscip Healthc (2014) 0.79
Glycemic control rate of T2DM outpatients in China: a multi-center survey. Med Sci Monit (2015) 0.77
Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest (2001) 23.21
Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med (2007) 18.45
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet (2006) 15.76
Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr (2006) 13.19
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril (2004) 12.87
A systematic review of adherence with medications for diabetes. Diabetes Care (2004) 7.67
Polycystic ovary syndrome. N Engl J Med (2005) 7.66
A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med (2012) 7.51
Diagnosis and classification of diabetes mellitus. Diabetes Care (2013) 6.83
Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care (2000) 6.21
Prevention of pediatric overweight and obesity. Pediatrics (2003) 5.95
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest (2010) 5.39
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab (1999) 5.28
Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol (2007) 3.83
Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction. Can J Diabetes (2013) 3.46
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes (2002) 3.21
Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care (2006) 3.16
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics (2003) 3.10
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
Impaired glucose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab (2004) 2.44
Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children: a prospective national surveillance study. Diabetes Care (2010) 2.23
Childhood obesity and type 2 diabetes mellitus. Pediatrics (2005) 2.08
Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet (2007) 2.01
Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr (2005) 1.94
AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun (2004) 1.89
Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care (2002) 1.88
Type 2 diabetes mellitus in minority children and adolescents. An emerging problem. Endocrinol Metab Clin North Am (1999) 1.77
Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescents. Pediatrics (2013) 1.76
The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care (2010) 1.76
Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment: a consensus statement of Shaping America's Health and the Obesity Society. Diabetes Care (2008) 1.74
Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study. Circulation (2005) 1.72
Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes (2008) 1.64
Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res (1995) 1.56
Incretin-based therapies: review of current clinical trial data. Am J Med (2010) 1.55
International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. Diabet Med (2008) 1.55
Food away from home, sugar-sweetened drink consumption and juvenile obesity. J Am Coll Nutr (2003) 1.54
Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics (2009) 1.52
Rosiglitazone monotherapy is effective in patients with type 2 diabetes. J Clin Endocrinol Metab (2001) 1.49
Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care (2003) 1.46
Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care (2003) 1.41
Low birth weight and high birth weight infants are both at an increased risk to have type 2 diabetes among schoolchildren in taiwan. Diabetes Care (2003) 1.39
Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care (2007) 1.38
Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med (2008) 1.38
Microvascular and macrovascular complications associated with diabetes in children and adolescents. Pediatr Diabetes (2009) 1.37
Minireview: update on incretin biology: focus on glucagon-like peptide-1. Endocrinology (2010) 1.29
The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol (2010) 1.29
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. J Endocrinol (2010) 1.28
Type 2 diabetes in children and adolescents. Pediatr Diabetes (2009) 1.26
Type 2 diabetes mellitus in youth: the complete picture to date. Pediatr Clin North Am (2005) 1.24
Type 2 diabetes in children: clinical aspects and risk factors. Horm Res (2002) 1.23
Physical activity for the prevention and management of youth-onset type 2 diabetes mellitus: focus on cardiovascular complications. Diab Vasc Dis Res (2007) 1.23
Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. Diabetes Care (2007) 1.22
Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol (2012) 1.19
Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell. Endocrinology (2011) 1.19
ISPAD Clinical Practice Consensus Guidelines 2006-2007. Type 2 diabetes mellitus in the child and adolescent. Pediatr Diabetes (2008) 1.13
Type 2 diabetes in children and adolescents in a 2-year follow-up: insufficient adherence to diabetes centers. Horm Res (2007) 1.11
Cardiovascular risk factors in youth with implications for aging: the Bogalusa Heart Study. Neurobiol Aging (2005) 1.10
Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 1.08
Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care (1997) 1.04
Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Arch Dis Child (2006) 1.04
Autoantibodies in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab (2002) 1.03
Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Int J Obes (Lond) (2005) 0.99
Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis. Obes Surg (2013) 0.97
Metabolic consequences of hepatic steatosis in overweight and obese adolescents. Diabetes Care (2012) 0.94
Short-term insulin therapy in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metab (2004) 0.94
Prevention and treatment of type 2 diabetes in youth. Horm Res (2006) 0.94
Albumin to creatinine ratio: a screening test with limitations. Am J Kidney Dis (2002) 0.93
Incretin-based therapies--review of the physiology, pharmacology and emerging clinical experience. Intern Med J (2011) 0.93
Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab (2000) 0.92
Treatment of type 2 diabetes in youth. Diabetes Care (2011) 0.91
Type 2 diabetes in children and adolescents. Lancet (2009) 0.89
Mechanisms of metformin action on glucose transport and metabolism in human adipocytes. Biochem Pharmacol (2010) 0.89
Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab (2002) 0.88
Screening for diabetic microalbuminuria in routine clinical care: which method? Arch Dis Child (1995) 0.88
Metformin Improves Insulin Signaling in Obese Rats via Reduced IKKbeta Action in a Fiber-Type Specific Manner. J Obes (2010) 0.86
Bariatric surgery, safety and type 2 diabetes. Obes Surg (2008) 0.86
Intrauterine growth restriction: diagnosis and management. A review. Minerva Ginecol (2009) 0.84
Resolution of type 2 diabetes following bariatric surgery: implications for adults and adolescents. Diabetes Technol Ther (2010) 0.83
FDA panel advises easing restrictions on rosiglitazone. BMJ (2013) 0.82
New potential adjuncts to treatment of children with type 1 diabetes mellitus. Pediatr Res (2009) 0.81
Distinguishing type 1 and type 2 diabetes at diagnosis. What is the problem? Pediatr Diabetes (2007) 0.79
Diagnosis and treatment of polycystic ovarian syndrome in adolescents. Curr Opin Endocrinol Diabetes Obes (2012) 0.78
DPP IV inhibitors: successes, failures and future prospects. Diabetes Metab Syndr (2012) 0.76
Polycystic ovary syndrome in adolescents. Curr Opin Obstet Gynecol (2012) 0.76
Nutrition therapy for overweight children and adolescents with type 2 diabetes. Curr Diab Rep (2005) 0.76
Surgical approach to adolescent obesity. Adolesc Med Clin (2004) 0.76